Abstract
Microsphere and particle technology represent the next-generation agents that have formed the basis of interventional oncology, an evolving subspecialty of interventional radiology. One of these platforms, yttrium-90 microspheres, is increasingly being used as a treatment modality for primary and secondary liver tumors. Due to the widespread use of radioembolization, a comprehensive review of the methodologic and technical considerations seems to be mandatory. This article summarizes the expert discussion and report from Mediterranean Interventional Oncology Live Congress (MIOLive 2017) that was held in Rome, Italy, integrating evidence-reported literature and experience-based perceptions, to assist not only residents and fellows who are training in interventional radiologists but also practicing colleagues who are approaching to this intra-arterial treatment.
| Original language | English |
|---|---|
| Pages (from-to) | 4014-4021 |
| Number of pages | 8 |
| Journal | European Review for Medical and Pharmacological Sciences |
| Volume | 21 |
| Issue number | 18 |
| Publication status | Published - 2017 |
All Science Journal Classification (ASJC) codes
- Pharmacology (medical)
Keywords
- MIOLive
- hepatic radioembolization
Fingerprint
Dive into the research topics of 'The ten commandments of hepatic radioembolization: expert discussion and report from Mediterranean Interventional Oncology (MIOLive) congress 2017'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver